Tibotec

Showing 2 posts of 2 posts found.

J&J hepatitis C drug begins phase III trials

February 23, 2011
Research and Development J&J, JJ, Johnson and Johnson, TMC435, Tibotec, hepatitis, hepatitis C

Johnson & Johnson has begun late stage trials of hepatitis C drug TMC435 as a first line treatment for the …

Pepscan and Tibotec sign peptides deal

September 15, 2010
Research and Development, Sales and Marketing CLIPS, HIV, J&J, JJ, Pepscan, Tibotec

Pepscan Therapeutics, the biotech firm focusing on protein mimicry technology has signed a deal with Tibotec. Netherlands-based Pepscan will use …

The Gateway to Local Adoption Series

Latest content